JANE STREET GROUP, LLC - IBERE PHARMACEUTICALS ownership

IBERE PHARMACEUTICALS's ticker is IBERU and the CUSIP is G46843127. A total of 35 filers reported holding IBERE PHARMACEUTICALS in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q4 2022$572,996
-16.4%
57,472
-16.9%
0.00%
Q3 2022$685,000
+22.3%
69,179
+21.1%
0.00%
Q2 2022$560,000
+1.1%
57,139
+1.1%
0.00%
Q1 2022$554,000
-2.3%
56,5450.0%0.00%
Q4 2021$567,000
+0.4%
56,545
-0.0%
0.00%
Q3 2021$565,000
-0.5%
56,554
+0.0%
0.00%
Q2 2021$568,000
+15.2%
56,545
+13.1%
0.00%
Q1 2021$493,00050,0000.00%
Other shareholders
IBERE PHARMACEUTICALS shareholders Q2 2021
NameSharesValueWeighting ↓
Hartree Partners, LP 1,285,000$12,914,250,0003.01%
Wealthspring Capital LLC 277,192$2,786,0000.70%
BASSO CAPITAL MANAGEMENT, L.P. 135,404$1,361,0000.17%
Omni Partners US LLC 364,371$3,662,0000.16%
Sage Mountain Advisors LLC 93,470$939,0000.16%
Castle Creek Arbitrage, LLC 253,446$2,540,0000.14%
Shaolin Capital Management LLC 396,200$3,982,0000.12%
Context Capital Management, LLC 115,053$1,156,0000.11%
PERISCOPE CAPITAL INC. 250,000$2,512,0000.08%
Magnetar Financial LLC 803,400$8,074,0000.08%
View complete list of IBERE PHARMACEUTICALS shareholders